| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Revenue | ||||||
37 | 869 | 508 | 0 | |||
Operating expenses: | ||||||
Research and development | ||||||
90,774 | 68,647 | 25,499 | 10,101 | |||
General and administrative | ||||||
11,284 | 8,781 | 4,464 | 3,258 | |||
Total operating expenses | ||||||
102,058 | 77,428 | 29,963 | 13,359 | |||
Operating loss | ||||||
-102,021 | -76,559 | -29,455 | -13,359 | |||
Interest expense, net | ||||||
-861 | -426 | 277 | - | |||
Other (expense) / income, net | ||||||
196 | 401 | 216 | 8 | |||
Total other (expense) / income | ||||||
-665 | -25 | 493 | 8 | |||
Loss before income taxes | ||||||
-102,686 | -76,584 | -28,962 | -13,351 | |||
Income tax expense | ||||||
444 | 472 | 444 | 113 | |||
Net loss and comprehensive loss | ||||||
-103,130 | -77,056 | -29,406 | -13,464 | |||
Net loss attributable to ordinary shareholders | ||||||
-103,130 | -77,056 | -29,406 | -13,464 | |||
Net loss per share attributable to ordinary shareholders – basic and diluted | ||||||
-7.10 | -8.82 | -170.84 | -568.87 | |||
Weighted average ordinary shares outstanding – basic and diluted | ||||||
14,518 | 8,734 | 172 | 23 | |||